January 12, 2022 During the past year, LuMind IDSC remained cautiously optimistic about treatment possibilities that…
adminJanuary 12, 2022
October 18, 2021 Dr. Nicole White, Hampus Hillerstrom, LuMind IDSC and a team of experts,…
adminOctober 18, 2021
Dr. James Hendrix, LuMind IDSC's Chief Scientific Officer, along with a team of Down syndrome…
adminOctober 13, 2021
October 7, 2021 From mom of four to Down syndrome researcher. Research Spotlight sat with…
adminOctober 7, 2021
LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage
August 18, 2021 LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The…
adminAugust 18, 2021
People with Down syndrome live longer and more independently now than ever before. Supported by…
adminJuly 15, 2021
“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as…
adminJuly 13, 2021
Burlington, MA, June 7, 2021 - Today marks an important milestone in Alzheimer’s disease research with…
adminJune 7, 2021